- Salmonella Outbreak Triggers Recall of Cucumbers in 26 States
- Switch From Animal to Plant Proteins Greatly Boosts Heart Health
- Workers Who Make Kitchen Countertops Face Big Lung Hazards
- When’s Best Time for Your COVID Booster? That May Depend on You
- Cervical Cancer Deaths Fell Dramatically After Advent of HPV Vaccine
- Antibiotics or Surgery: What’s Best for Child Appendicitis?
- Newer Epilepsy Meds Safe During Pregnancy, Won’t Affect Kids’ Neurodevelopment
- CTE Plus Family History of Mental Illness Raises Odds for Aggression
- Over 100,000 U.S. Youth Battle Inflammatory Bowel Disease
- Smoker or Former Smoker? Here Are 4 Key Things You Need to Know
Health Highlights: May 29, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
U.S. Abortion Pill Rule Should be Suspended During Pandemic: Lawsuit
A U.S. government rule that requires women to visit a hospital, clinic or medical office to get the abortion pill mifepristone should be suspended during the coronavirus pandemic, according to a lawsuit filed by the American Civil Liberties Union on behalf of the American College of Obstetricians and Gynecologists and other groups.
The lawsuit against the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services says the rule needlessly puts women’s health at risk and that they should able to fill prescriptions for the drug by mail, the Associated Press reported.
“Of the more than 20,000 drugs regulated by the FDA, mifepristone is the only one that patients must receive in person at a hospital, clinic or medical office, yet may self-administer, unsupervised, at a location of their choosing,” according to the federal lawsuit filed in Maryland.
Mifepristone is approved by the FDA to be used in combination with a second drug, misoprostol, to end an early pregnancy or manage a miscarriage.
Copyright © 2024 HealthDay. All rights reserved.